BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9024516)

  • 1. Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients.
    Barriga FJ; Varas M; Potin M; Sapunar F; Rojo H; Martinez A; Capdeville V; Becker A; Vial PA
    Med Pediatr Oncol; 1997 Mar; 28(3):196-200. PubMed ID: 9024516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer.
    Carratalà J; Niubó J; Fernández-Sevilla A; Juvé E; Castellsagué X; Berlanga J; Liñares J; Gudiol F
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2200-4. PubMed ID: 10471564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
    Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
    Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms.
    Schwartz C; Henrickson KJ; Roghmann K; Powell K
    J Clin Oncol; 1990 Sep; 8(9):1591-7. PubMed ID: 2202792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial.
    Henrickson KJ; Axtell RA; Hoover SM; Kuhn SM; Pritchett J; Kehl SC; Klein JP
    J Clin Oncol; 2000 Mar; 18(6):1269-78. PubMed ID: 10715297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia.
    Kim SH; Kang CI; Kim HB; Youn SS; Oh MD; Kim EC; Park SY; Kim BK; Choe KW
    Infect Control Hosp Epidemiol; 2003 Dec; 24(12):897-904. PubMed ID: 14700404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simplified method of antibiotic lock therapy for Broviac-Hickman catheters using a CLC 2000 connector device.
    Cesaro S; Cavaliere M; Spiller M; Rossi L; Magagna L; Gavin P; Bonetto M; Carli M
    Support Care Cancer; 2007 Jan; 15(1):95-9. PubMed ID: 16816960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children.
    Rackoff WR; Weiman M; Jakobowski D; Hirschl R; Stallings V; Bilodeau J; Danz P; Bell L; Lange B
    J Pediatr; 1995 Jul; 127(1):147-51. PubMed ID: 7608801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study.
    Elishoov H; Or R; Strauss N; Engelhard D
    Medicine (Baltimore); 1998 Mar; 77(2):83-101. PubMed ID: 9556701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between neutropenia and the incidence of bacteremia associated with indwelling central venous catheters in febrile pediatric cancer patients.
    Gorelick MH; Owen WC; Seibel NL; Reaman GH
    Pediatr Infect Dis J; 1991 Jul; 10(7):506-10. PubMed ID: 1876466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empiric treatment with once-daily cefonicid and gentamicin for febrile non-neutropenic pediatric cancer patients with indwelling central venous catheters.
    Averbuch D; Makhoul R; Rotshild V; Weintraub M; Engelhard D
    J Pediatr Hematol Oncol; 2008 Jul; 30(7):527-32. PubMed ID: 18797200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
    Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
    Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients.
    Gudiol C; Arnan M; Aguilar-Guisado M; Royo-Cebrecos C; Sánchez-Ortega I; Montero I; Martín-Gandul C; Laporte-Amargós J; Albasanz-Puig A; Nicolae S; Perayre M; Berbel D; Tebe C; Riera J; Sureda A; Cisneros JM; Carratalà J
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
    Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
    Trials; 2018 May; 19(1):264. PubMed ID: 29720244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic lock with vancomycin and urokinase can successfully treat colonized central venous catheters in pediatric cancer patients.
    De Sio L; Jenkner A; Milano GM; Ilari I; Fidani P; Castellano A; Gareri R; Donfrancesco A
    Pediatr Infect Dis J; 2004 Oct; 23(10):963-5. PubMed ID: 15602201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
    Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
    J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis.
    Campos RP; do Nascimento MM; Chula DC; Riella MC
    J Am Soc Nephrol; 2011 Oct; 22(10):1939-45. PubMed ID: 21852579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study.
    Fernandez-Hidalgo N; Almirante B; Calleja R; Ruiz I; Planes AM; Rodriguez D; Pigrau C; Pahissa A
    J Antimicrob Chemother; 2006 Jun; 57(6):1172-80. PubMed ID: 16597634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis in neonates.
    Spafford PS; Sinkin RA; Cox C; Reubens L; Powell KR
    J Pediatr; 1994 Aug; 125(2):259-63. PubMed ID: 8040776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid versus vancomycin antibiotic lock solution for the prevention of nontunneled catheter-related blood stream infections in hemodialysis patients: a prospective randomized study.
    Sofroniadou S; Revela I; Smirloglou D; Makriniotou I; Zerbala S; Kouloubinis A; Samonis G; Iatrou C
    Semin Dial; 2012 May; 25(3):344-50. PubMed ID: 22074188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.